During the past decade, Ehime University Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 15 clinical trials were completed, i.e. on average, 34.9% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 13 clinical trials were completed. i.e. 48.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ehime University Hospital" #1 sponsor was "Pfizer" with 7 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Janssen Pharmaceutical K.K." with 3 trials sponsored, "Kyowa Kirin Co., Ltd." with 3 trials sponsored and "National Cancer Institute (NCI)" with 3 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ehime University Hospital" #1 collaborator was "NRG Oncology" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Ehime University Hospital" are "Ovarian Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Fallopian Tube Cancer" (3 trials), "Palmoplantar Pustulosis" (2 trials) and "Polycythemia Vera (PV)" (2 trials). Many other conditions were trialed in "Ehime University Hospital" in a lesser frequency.

Most popular intervention types in "Ehime University Hospital" are "Drug" (45 trials), "Biological" (6 trials), "Other" (6 trials), "Procedure" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (4 trials), "Amivantamab" (3 trials), "Apremilast" (3 trials) and "Questionnaire Administration" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ehime University Hospital" are 43 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Ehime University Hospital". undefined are not yet recruiting, 13 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Ehime University Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ehime University Hospital, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".